EMD Serono Launches New Electronic Growth Hormone Injection Device
Growth Hormone Injection Device
EMD Serono announced availability of easypod, the first of its kind automated device in the growth hormone therapeutic area. easypod was developed for the administration of Saizen [somatropin (rDNA origin) for injection], the company's treatment for growth hormone deficiency.
A 2007 Gold Medal recipient of the Medical Design Excellence Awards, easypod was designed in conjunction with patients, caregivers and healthcare professionals to answer the need for a device that provided simple everyday use while monitoring patient adherence. On October 31, 2007, easypod received approval from the US Food and Drug Administration (FDA) and is now available to patients through their healthcare providers.
"As a physician who treats children with growth hormone deficiency, I am encouraged by the new technology in easypod," said Henry Anhalt, D.O., FAAP, FACOP, FACE, CDE, Director of the Division of Pediatric Endocrinology and Diabetes at Saint Barnabas Medical Center. "It is the first growth hormone delivery device that allows healthcare professionals to preset their patient's daily dose in advance and then monitor their compliance to the treatment schedule."
Over seven hundred patients, caregivers and healthcare professionals were surveyed for input on how to improve upon delivery systems for growth hormone therapy during the development phase of easypod. One of the key features of easypod is preset dosing, which means patients no longer have to set their dose each day. Another unique feature is the dose confirmation screen that notifies patients when they have properly administered their treatment. easypod also logs the date and dose of each injection, allowing healthcare professionals to monitor patient adherence.
"We are proud to bring products like easypod to market that utilize breakthrough technology to provide patients and healthcare professionals with devices that are simple to use," said Jim Hoyes, Chief Commercial Officer, EMD Serono, Inc. "The collaboration and research used for the design of easypod allowed us to develop an innovative device that provides more real-time data for physicians than ever before, meeting the unmet needs of patients and caregivers."
As with other EMD Serono growth hormone delivery deficiency devices, easypod was designed with patients in mind. easypod has a sleek, ergonomic shape and is similar in size to a juice box. The device also features a hidden needle intended to help reduce patient anxiety.
easypod was the recipient of a 2007 Gold Medal from the Medical Design Excellence Awards, the premier awards program for the medical technology community. The Awards recognize the achievements of medical product manufacturers who are responsible for the groundbreaking innovations that are changing the face of healthcare. easypod was recognized for its ergonomic design as a self-care product.
"Parents and patients are always looking for ways to make taking their medicine and staying on therapy as convenient as possible," said Mary Andrews, co-founder and CEO of the MAGIC Foundation. "It's a win for parents and patients whenever there's a new product, like easypod, that helps with these treatment goals."
EMD Serono is supporting the introduction of easypod with a comprehensive training program intended to provide training for healthcare professionals who specialize in the treatment of growth hormone deficiency. Interested healthcare professionals can request a training session on the setup, use and features of easypod by contacting the company.
easypod is currently available in a number of European and Latin American countries, as well as Australia and Canada and now the United States.